Please ensure Javascript is enabled for purposes of website accessibility
Eric Volkman

Eric Volkman


Eric has been writing about stocks and finance since the mid-1990s, when he lived in Prague, Czech Republic. Over the course of a varied career, he has also been a radio newscaster, an investment banker, and a bass player in a selection of rock and roll bands. A native New Yorker, he currently lives in Los Angeles.

Recent articles


Curaleaf's Q1 Results: Is the CEO Shift a Reason to Buy the Stock?

The newly named CEO displaces a man who will be heading up an intriguing new business unit at the pot company.

Female hand wielding a large pair of scissors

Why Appian Shares Got Slammed On Monday

Although first-quarter results were promising, one researcher has shaved its price target on the company's stock.

Person in a lab looking through a microscope

Why Axsome Therapeutics Stock Got Mashed on Monday

Investors were hardly impressed with the closing of a rights deal.


Why DocuSign Stock Got Pummeled Today

An executive resignation spooks nervous investors.


Why Tonix Pharmaceuticals Got Crushed Today

Now is not a great time for pre-revenue biotechs to be reporting earnings.


Why Intercontinental Exchange Took a Big Hit After Q1 Results

The New York Stock Exchange's owner is opening its wallet for a new acquisition.


Why Hexo Stock Wilted So Badly This Week

A dilutive new share issue and negative sentiment about pot stocks generally combine for a double-digit share price dip.


Why Blue Apron Was a Tasty Stock This Week

The meal kit specialist delivered a box of good news about its finances.

Young woman at a desk using a PC and tablet computer simultaneously

Why Appian Stock Topped the Market Today

There's nothing like a pair of quarterly beats to make shareholders happy.


Why DoorDash Stock Flopped on Friday

The company beat expectations on first-quarter revenue, but whiffed on the bottom line.


Why Tesla Stock Was Slumping on Friday

The electric vehicle powerhouse might, or might not, be cranking up production at its Shanghai gigafactory.


Why Revolve Group Stock Was Down by Over 20% This Week

Counterintuitively, the shares suffered a big drop after the retailer delivered a better-than-expected first quarter.


Why DraftKings Stock Was a Good Bet This Week

The company is the proud new owner of a complementary online gambling business.


Why Clovis Oncology Stock Was Plummeting This Week

Investors bailed from the company after a quarterly results and operational update.


Why TripAdvisor Soared High Above the Market Today

The company more than doubled its revenue in the inaugural quarter of 2022.

Two people seated at a lab desk featuring a PC screen and microscope

Why Global Blood Therapeutics Stock Was Sickly Today

The bears pounced on the company despite a first-quarter bottom-line beat.

Woman in a lab looking through a microscope

Why BioCryst Stock Lost Nearly 4% of Its Value Today

The biotech whiffs on both revenue and profitability for its first quarter, and indicates more losses are in store.


Why Royal Caribbean Got Thrashed on Thursday

The company is indisputably in recovery mode, but it whiffed on first-quarter estimates.


Why eBay Stock Tanked Today

Investors weren't pleased with the company's first-quarter results, to put it mildly.


Teva's Q1 Results: Is the Stock About to Crash?

The company met analyst expectations for revenue and profitability, yet that's not necessarily a good thing.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.